Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Combination in patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment with Metformin alone, Sulfonylurea alone, Basal Insulin alone or Metformin in Combination with either Sulfonylurea or Basal Insulin In a 26-week, double-blind trial (Trial 5, NCT02827708), 324 adult patients with moderate renal impairment (eGFRCKD-EPI 30 to 59 mL/min/1.73 m2) were randomized to semaglutide tablets 14 mg orally once daily or placebo once daily
Performance protocol (10 mg/week) produces faster body composition changes
The pivotal data come from randomized, placebo-controlled Phase 3 trials in the STEP program
Simply place the recommended dose under your tongue and let it sit for a minute before swallowing
US$ 22.83
US$ 20.76
US$ 20.08
US$ 26.39
US$ 23.19
US$ 25.10
/i.s3.glbimg.com/v1/AUTH_da025474c0c44edd99332dddb09cabe8/internal_photos/bs/2026/e/H/WoQ8xiSRSUqg2BFtZe3g/retatrutide-40mg-new-8sa80f3e.png)
US$ 24.11
US$ 29.85
